Literature DB >> 14978083

Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice.

Nico Ghilardi1, Noelyn Kljavin, Qi Chen, Sophie Lucas, Austin L Gurney, Frederic J De Sauvage.   

Abstract

The heterodimeric cytokine IL-23 consists of a private cytokine-like p19 subunit and a cytokine receptor-like subunit, p40, which is shared with IL-12. Previously reported IL-12p40-deficient mice have profound immune defects resulting from combined deficiency in both IL-12 and IL-23. To address the effects of specific IL-23 deficiency, we generated mice lacking p19 by gene targeting. These mice display no overt abnormalities but mount severely compromised T-dependent humoral immune responses. IL-23p19(-/-) mice produce strongly reduced levels of Ag-specific Igs of all isotypes, but mount normal T-independent B cell responses. In addition, delayed type hypersensitivity responses are strongly impaired in the absence of IL-23, indicating a defect at the level of memory T cells. T cells stimulated with IL-23-deficient APCs secrete significantly reduced amounts of the proinflammatory cytokine IL-17, and IL-23-deficient mice phenotypically resemble IL-17-deficient animals. Thus, IL-23 plays a critical role in T cell-dependent immune responses, and our data provide further support for the existence of an IL-23/IL-17 axis of communication between the adaptive and innate parts of the immune system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978083     DOI: 10.4049/jimmunol.172.5.2827

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  83 in total

1.  A novel immunoregulatory function for IL-23: Inhibition of IL-12-dependent IFN-γ production.

Authors:  Amy N Sieve; Karen D Meeks; Suheung Lee; Rance E Berg
Journal:  Eur J Immunol       Date:  2010-08       Impact factor: 5.532

2.  IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans.

Authors:  Shinji Kagami; Heather L Rizzo; Stephen E Kurtz; Lloyd S Miller; Andrew Blauvelt
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

3.  IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung.

Authors:  Shabaana A Khader; Lokesh Guglani; Javier Rangel-Moreno; Radha Gopal; Beth A Fallert Junecko; Jeffrey J Fountain; Cynthia Martino; John E Pearl; Michael Tighe; Yin-yao Lin; Samantha Slight; Jay K Kolls; Todd A Reinhart; Troy D Randall; Andrea M Cooper
Journal:  J Immunol       Date:  2011-10-14       Impact factor: 5.422

Review 4.  IL-17A-producing neutrophil-regulatory Tn lymphocytes.

Authors:  Klaus Ley; Emily Smith; Matthew A Stark
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

5.  The immunobiology of colitis and cholangitis in interleukin-23p19 and interleukin-17A deleted dominant negative form of transforming growth factor beta receptor type II mice.

Authors:  Yugo Ando; Guo-Xiang Yang; Masanobu Tsuda; Kazuhito Kawata; Weici Zhang; Takahiko Nakajima; Koichi Tsuneyama; Patrick Leung; Zhe-Xiong Lian; Kazuichi Okazaki; William M Ridgway; Gary L Norman; Aftab A Ansari; Xiao-Song He; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

6.  The effects of PDL-Ig on collagen-induced arthritis.

Authors:  Guohua Wang; Ping Hu; Jing Yang; Guanxin Shen; Xiongwen Wu
Journal:  Rheumatol Int       Date:  2009-12-25       Impact factor: 2.631

7.  Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

Authors:  Sergei I Grivennikov; Kepeng Wang; Daniel Mucida; C Andrew Stewart; Bernd Schnabl; Dominik Jauch; Koji Taniguchi; Guann-Yi Yu; Christoph H Osterreicher; Kenneth E Hung; Christian Datz; Ying Feng; Eric R Fearon; Mohamed Oukka; Lino Tessarollo; Vincenzo Coppola; Felix Yarovinsky; Hilde Cheroutre; Lars Eckmann; Giorgio Trinchieri; Michael Karin
Journal:  Nature       Date:  2012-11-08       Impact factor: 49.962

8.  Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.

Authors:  Marcin Kortylewski; Hong Xin; Maciej Kujawski; Heehyoung Lee; Yong Liu; Timothy Harris; Charles Drake; Drew Pardoll; Hua Yu
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

9.  Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.

Authors:  Rupali Das; Xiao Chen; Richard Komorowski; Martin J Hessner; William R Drobyski
Journal:  Blood       Date:  2008-12-04       Impact factor: 22.113

10.  IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice.

Authors:  Colin Edgerton; José C Crispín; Chantal M Moratz; Estelle Bettelli; Mohamed Oukka; Milomir Simovic; Athina Zacharia; Ryan Egan; Jie Chen; Jurandir J Dalle Lucca; Yuang-Taung Juang; George C Tsokos
Journal:  Clin Immunol       Date:  2008-12-05       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.